Department of Medical Biology and Genetic, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
Fam Cancer. 2013 Mar;12(1):111-7. doi: 10.1007/s10689-012-9586-7.
von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome caused by mutations in the VHL tumor suppressor gene. In a family with VHL, we identified a novel missense mutation (N78D), which affects a fully conserved residue in the VHL protein. Interestingly, several other missense mutations reported at same codon in the VHL protein that might be associated with a low risk of renal cell carcinoma (RCC) but not pheochromocytoma appear to be associated with a VHL type 1 phenotype. At the moment, RCC is present in none of the affected mutation carriers in the family described here. In contrast to other missense changes at codon 78, the change in our VHL family is predicted to have a mild effect on VHL function, which apparently is insufficient to cause predisposition to RCC. Our findings suggest that the risk of RCC in VHL is attributable to the severity of the amino acid substitution at this particular codon in the VHL protein.
冯·希佩尔-林道(VHL)病是一种遗传性肿瘤综合征,由 VHL 肿瘤抑制基因的突变引起。在一个 VHL 家族中,我们鉴定出一种新的错义突变(N78D),它影响 VHL 蛋白中完全保守的残基。有趣的是,VHL 蛋白中同一密码子报道的其他几个错义突变,尽管可能与肾细胞癌(RCC)的低风险相关,但不与嗜铬细胞瘤相关,似乎与 VHL 1 型表型相关。目前,在描述的家族中,没有一个受影响的突变携带者患有 RCC。与密码子 78 处的其他错义变化不同,我们的 VHL 家族中的变化预计对 VHL 功能的影响轻微,显然不足以导致 RCC 的易感性。我们的研究结果表明,VHL 中 RCC 的风险归因于 VHL 蛋白中该特定密码子处氨基酸取代的严重程度。